Seminar on Access to Quality-assured medicines The Be-cause health seminar on building universal access to quality-assured medicines gathered over 80 participants at the DGD headquarters in Brussels on November 20th, for looking at how national and international funding agencies, as well Belgian stakeholders, can contribute to this aim.
Medicines and ethics Poor-quality medicines are especially prevalent in low- and middle-income countries. They represent a threat for individual and public health, by causing therapeutic failure or direct toxicity, by contributing to the emergence of resistance, and by eroding trust in health systems. Unfortunately, they often go undetected (due to the lack of efficient reporting systems), or they are only detected after treatment failure or toxicity become evident.
A call for strengthening the regulatory capacities of pharmaceuticals in the South Poor-quality medicines are still a major and hidden threat to many individuals and health systems in low-income countries. The collaboration between ITM researchers, master’s students and QUAMED (Quality Medicines for All) on the quality systems of pharmaceutical distributors provides an opportunity to share the findings of operational actors with the public health community.
Plenary talk of prof. Hogerzeil at ECTMIH on essential medicines The plenary talk of prof. Hogerzeil at ECTMIH on essential medicines is now available online.
Reproductive health supplies - recommendations on availability, quality and affordability Insights and recommendations, as well as ppt are made available from 8th Nov. 2017 Seminar on access to quality medicines and supplies for sexual reproductive health and rights.
Minister De Croo and Belgian actors from the international health cooperation sign commitment on quality of medicines The Belgian Development Cooperation will better monitor the quality of pharmaceutical products in developing countries.
Poor quality medicines on the programme at ECTMIH, Belgium Dr Raffaella Ravinetto, senior researcher at the ITM Public Health Department and chair of the Be-cause health Medicines Working Group, said: “Despite an increasing awareness of the problem of poor quality medicines, the divide in pharmaceutical quality between the North and the South remains insufficiently addressed.
Publication by Jacques Pinel Publication by Jacques Pinel († 2015), pioneer in the fight for universal access to quality-assured medicines, titled "Poor-quality medicines: a life-threatening issue. Rare in rich countries, frequent in developing countries"